MAIA
MAIA Biotechnology, Inc.
There isn't enough reported data to score MAIA yet.
MAIA Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
MAIA's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
MAIA PE Valuation
MAIA has no meaningful PE right now: it lost money over the past year.
MAIA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| -- | |
| -- | |
| Limited | |
| High |
Analysts expect MAIA's earnings, revenue and profitability to hold roughly steady.
MAIA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.48 | +$0.21 |
| Q2 2026 | -$0.63 | -$0.10 |
| Q1 2026 | -$0.68 | +$0.07 |
| Q4 2025 | -$0.70 | +$0.35 |
| Q3 2025 | -$0.69 | +$0.68 |
| Q2 2025 | -$0.53 | +$1.09 |
| Q1 2025 | -$0.75 | +$0.82 |
| Q4 2024 | -$1.05 | +$0.44 |
MAIA is still losing money, but far less than before: $0.48 per share over the past year, against $1.67 at its worst in early 2023.
MAIA Quarterly Revenue
MAIA's revenue is shrinking: $0 last quarter.
MAIA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.3M | -$2.8M |
| Q2 2026 | -$6.8M | -$2.6M |
| Q1 2026 | -$5.3M | -$1.1M |
| Q4 2025 | -$7M | -$3.1M |
| Q3 2025 | -$3.5M | +$38.2K |
| Q2 2025 | -$4.1M | +$549.4K |
| Q1 2025 | -$4.2M | -$615.5K |
| Q4 2024 | -$3.9M | +$84.3K |
MAIA has burned cash in almost every quarter: −$25M over the past year, against −$16M the year before.
MAIA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +70.6K shares |
| 1 year | +101% | +30.6M shares |
| 3 years | +556% | +51.6M shares |
| 5 years | +472% | +50.2M shares |
MAIA has 61M diluted shares, up 101% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
MAIA Net Leverage
MAIA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MAIA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.2 | Neutral |
| Stochastic | 6.9 | Oversold |
MAIA's weekly RSI is 34 (neutral) and its Stochastic is 7 (oversold).
MAIA PE vs Healthcare Sector
MAIA has no meaningful PE right now: it lost money over the past year.
MAIA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.13 | 11% below |
| 20 week MA | $1.26 | 20% below |
| 50 week MA | $1.44 | 30% below |
| 100 week MA | $1.56 | 35% below |
| 200 week MA | $2.06 | 51% below |
MAIA is in a downtrend: it's below all five of its weekly moving averages, and 51% below its 200-week average.
MAIA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $5.80 | $3.35 | -42% |
| 2023 | $3.35 | $1.17 | -65% |
| 2024 | $1.17 | $2.09 | +79% |
| 2025 | $2.09 | $1.57 | -25% |
| 2026 YTD | $1.57 | $1.01 | -36% |
MAIA has finished lower in three of the last four years. It's down 36% so far in 2026.